Lusutrombopag
RxNorm 2054984
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2054984 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lusutrombopag.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Lusutrombopag
(Atom ID: 10330312)
PTPrescribable
Designated preferred name (PT):
Lusutrombopag
(Atom ID: 10806313)
FNPrescribable
Full form of descriptor (FN):
Lusutrombopag (substance)
(Atom ID: 10806314)
PTPrescribable
Designated preferred name (PT):
Lusutrombopag-containing product
(Atom ID: 10806317)
FNPrescribable
Full form of descriptor (FN):
Product containing lusutrombopag (medicinal product)
(Atom ID: 10811611)
Patient Education
Lusutrombopag
Lusutrombopag is used treat thrombocytopenia (a low number of platelets [type of blood cell needed for blood clotting]) in patients with chronic (ongoing) liver disease who are scheduled to have a medical or dental procedure to help prevent bleeding complications. Lusutrombopag is in a class of medications called thrombopoietin (TPO) receptor agonists. It works by causing the body to produce more platelets.
[Learn More]
* Please review the disclaimer below.